Lion Biotechnologies Inc (LBIO)

6.35
0.10 1.60
NASDAQ : Health Care
Prev Close 6.25
Open 6.65
Day Low/High 6.25 / 6.70
52 Wk Low/High 4.90 / 9.58
Volume 158.12K
Avg Volume 427.00K
Exchange NASDAQ
Shares Outstanding 62.35M
Market Cap 433.34M
EPS -3.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of Upcoming Deadline To File Lead Plaintiff Papers In Lion Biotechnologies, Inc. (NASDAQ:LBIO) Securities Case

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that June 13, 2017 is the last day to file lead plaintiff papers in the securities lawsuit...

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Lion Biotechnologies, Inc. Shareholders And A Lead Plaintiff Deadline Of June 13, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Lion Biotechnologies, Inc.

The Klein Law Firm Notifies Investors Of A Class Action Filed On Behalf Of Lion Biotechnologies, Inc. Shareholders And A Lead Plaintiff Deadline Of June 13, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Lion Biotechnologies, Inc.

LBIO INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Lion Biotechnologies, Inc. And A Lead Plaintiff Deadline Of June 13, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Lion Biotechnologies,...

SHAREHOLDER DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Lion Biotechnologies, Inc. To Contact The Firm Before Imminent Lead Plaintiff Deadline

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Lion Biotechnologies, Inc.

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess Of $100,000 From Investment In Lion Biotechnologies, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...

LBIO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Lion Biotechnologies, Inc. And A Lead Plaintiff Deadline Of June 13, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Lion Biotechnologies,...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Lion Biotechnologies, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of June 13, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Lion Biotechnologies, Inc.

Law Offices Of Howard G. Smith Reminds Lion Biotechnologies, Inc. Investors Of Pending Lawsuit And Upcoming Lead Plaintiff Deadline

Law Offices of Howard G. Smith reminds investors of the upcoming  June 13, 2017 deadline to file a lead plaintiff motion in the class action lawsuit filed on behalf of a class of investors who purchased or...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Lion Biotechnologies, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of June 13, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Lion Biotechnologies, Inc.

First Week of LBIO July 21st Options Trading

Investors in Lion Biotechnologies Inc saw new options become available this week, for the July 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LBIO options chain for the new July 21st contracts and identified one put and one call contract of particular interest.

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of Upcoming Deadline To File Lead Plaintiff Papers In Lion Biotechnologies, Inc. (NASDAQ:LBIO) Securities Case

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that June 13, 2017 is the last day to file lead plaintiff papers in the securities lawsuit...

Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme

Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme

Lion Biotechnologies, XBiotech and Halozyme Therapeutics were among the biotech movers in premarket trading on Friday.

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Lion Biotechnologies, Inc.

Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Lion Biotechnologies, Inc.

Robbins Arroyo LLP: Lion Biotechnologies, Inc. (LBIO) Misled Shareholders According To A Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Lion Biotechnologies, Inc.

Lion Biotechnologies Enters Oversold Territory (LBIO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of Upcoming Deadline To File Lead Plaintiff Papers In Lion Biotechnologies, Inc. (LBIO) Securities Case

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that June 13, 2017 is the last day to file lead plaintiff papers in the securities lawsuit...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Lion Biotechnologies, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Lion Biotechnologies, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Lion Biotechnologies, Inc.

Short Interest In Lion Biotechnologies Drops 30.6%

The most recent short interest data has been released for the 04/13/2017 settlement date, which shows a 1,181,308 share decrease in total short interest for Lion Biotechnologies Inc , to 2,683,777, a decrease of 30.56% since 03/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.